• Maximiliano Vergara, Nicolás Triantafilo, James Campbell, María José García, Patricio Rojas, Vicente Sandoval, Mauricio Sarmiento M, and Mauricio Ocqueteau M.
• Departamento de Hematología, Facultad de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile.
• Rev Med Chil. 2023 Aug 1; 151 (8): 992998992-998.

IntroductionHodgkin Lymphoma (HL) is a prevalent hematological cancer in the world and Chile.ObjectivesShow the experience of 10 years treating HL in a Chilean academic center. Additionally, it exposes the diagnostic performance of PET CT and Bone Marrow Biopsy.Material And MethodsWe conducted a retrospective cohort study to collect data and outcomes of patients treated in our center.Results82 patients were analyzed (Average age, 35 years old; the ratio between men and women was 1.9:1). Progression-free survival was 88.6% and 66.4% for localized and advanced stages, respectively. PET as a staging strategy had better sensitivity than Marrow Biopsy.ConclusionsThe clinical results of the patients treated in this Chilean teaching center were comparable to the international literature. Additionally, PET CT proved to be a superior tool in diagnosis and staging compared to biopsy in our patients.

21 keywords...

hide…